Head & Neck Cancer

In this week’s episode of CURE Talks Cancer, we spoke with Jill Kelly – wife of Pro Football Hall of Fame Quarterback Jim Kelly – about his bout with head and neck cancer, and how she copes as a caregiver.

Patients with head and neck cancer appeared to be receptive to lung cancer screening, according to recent research performed at the University of Iowa Hospitals and Clinics.

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.

Patients with cancer are 10 times less likely to have an opioid-associated death, according to recent research conducted at Duke University.

Immunotherapy pioneers James P. Allison, Ph.D., and Tasuku Honjo, M.D., Ph.D., have won the 2018 Nobel Prize in Physiology or Medicine for their research that eventually led to the use of immune checkpoint inhibitors to treat cancer.

In this episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.

The mouth is also part of the body, and yet, it is only in the past few years that oncologists have begun recommending patients see a dentist before they begin treatment to be sure the teeth and gums are in good shape.

The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.

In this special edition of CURE Talks Cancer, we spoke with NFL Hall of Fame quarterback Jim Kelly about his experience with head and neck cancer, and the humbling experience of winning the Jimmy V award for Perseverance at this year’s ESPY Awards.